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Abstract 
Structural and functional implications of positive selection at the 
primate angiogenin gene 
Introduction 
Angiogenesis, the formation of new blood vessels, is a primordial process in development and its 
dysregulation has a central role in the pathogenesis of many diseases. Angiogenin (ANG), a peculiar 
member of the RNase A family, is a potent inducer of angiogenesis, involved in many different types of 
cancer, amyotrophic lateral sclerosis and appears also to have a role in the immune innate defense. 
The evolutionary path of this family has been highly dynamic, with positive (diversifying) selection likely 
playing a strong role. In this work I used a combined gene and protein level bioinformatics approach to 
determine the main sites under diversifying selection on the primate ANG gene and analyze its 
structural and functional implications. 
Results 
I obtained evidence for positive selection in the primate ANG gene. Site specific analysis pointed out 15 
sites with a high probability for being under positive selection, five of which also exhibited a high 
number of drastic changes in amino acid properties. The mapping of these sites in the ANG 3D-
structure described five clusters, four of which were located in functional regions: two in the active site 
region, one in the nuclear localization signal and one in the cell-binding site. Eight of the 15 sites under 
selection in the primate ANG gene were highly or moderately conserved in the RNase A family, 
suggesting that this was a directed event and not simply due to structural or functional permissiveness. 
Moreover, 11 sites were exposed to the surface of the protein indicating that they may influence the 
protein-protein interactions performed by ANG. 
Conclusions 
Through a combined gene and protein level analysis 15 sites under positive selection were identified in 
the primate ANG gene. These sites mapped onto the main functional regions of the ANG protein. The 
fact that evidence for positive selection is present in all ANG regions required for angiogenesis may be a 
good indication that angiogenesis is the process under selection. However, other possibilities to be 
considered arise from the possible involvement of ANG in innate immunity and the potential influence or 
co-evolution with its interacting proteins and ligands.  
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Resumo 
Implicações estruturais e funcionais da selecção positiva no gene 
da angiogenina nos primatas 
Introdução 
A angiogénese, processo de formação de novos vasos sanguíneos, é um evento primordial do 
desenvolvimento, cuja desregulação está subjacente à patogenia de muitas doenças. A angiogenina 
(ANG), uma peculiar enzima da superfamília das RNase A com capacidade angiogénica, está implicada 
em múltiplos tipos de cancro e na esclerose lateral amiotrófica, para além de desempenhar um 
possível papel na imunidade inata. A história evolutiva desta enzima e da sua superfamília tem sido 
altamente dinâmica, com um trajecto aparentemente marcado pela selecção natural positiva 
(diversificante). Neste estudo utilizei uma abordagem bioinformática combinada ao nível do gene e da 
proteína, para determinar as principais posições sob selecção positiva no gene ANG de primatas e 
analisar as suas implicações estruturais e funcionais.  
Resultados 
Foram obtidas evidências de selecção positiva no gene ANG dos primatas. As análises realizadas 
indicaram 15 posições com uma elevada probabilidade de estarem sob selecção positiva, cinco das 
quais apresentaram também um elevado número de alterações drásticas de propriedades químicas 
e/ou estruturais. Através do mapeamento na estrutura 3D da proteína verificou-se que as posições sob 
selecção descreviam cinco grupos, quatro dos quais localizados em regiões funcionais: dois no centro 
activo, um no sinal de localização nucleolar e um no local de ligação celular. Oito das 15 posições sob 
selecção no gene ANG dos primatas são altamente ou moderadamente conservados na família das 
RNase A, sugerindo tratar-se evento dirigido e específico. Adicionalmente, 11 destas posições 
encontram-se à superfície da proteína podendo, por isso, influenciar as interacções por ela efectuadas. 
Conclusões 
Através de uma abordagem combinada gene-proteína foram identificadas quinze posições sob selecção 
positiva no gene ANG dos primatas, maioritariamente localizadas em regiões funcionais da proteína. O 
facto de existirem evidências de selecção positiva nas três regiões desta enzima consideradas 
essenciais para a angiogénese parece indiciá-la como sendo o processo sob selecção. No entanto, 
outras possibilidades a considerar advêm do possível envolvimento da ANG na imunidade inata e da 
potencial influência ou co-evolução com os seus ligandos e proteínas interactuantes. 
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1.1. Prelude 
One of the classic premises of human biology is the assumption that the molecular processes and 
the genes underlying them are conserved from other species. This is probably best reflected by the 
numerous animal models developed to study human (patho)physiology, from microorganisms to 
mammals. Although this strategy has yielded very important advances, it has also contributed to 
propagate the idea of 'absolute' conservation, failing to address the specificities of human biology and 
disease. This issue has been known for a long time; however the interest in characterizing human 
specific traits at the molecular and genetic level has only recently risen.  
One of the emergent approaches in studying human specific traits is the identification of the selective 
forces that gave rise to them. Traditionally, two types of selection are considered: purifying (negative) 
selection, promoting the conservation of current phenotypes and diversifying (positive) selection, 
promoting the emergence of new phenotypes. Positive selection leaves detectable signatures on the 
sequence of the influenced genes, like rapid interspecific divergence of functional sites or the reduction 
of intraspecific polymorphisms. Identifying these signatures, the genes under positive selection and the 
effects on the proteins they encode is a central step to obtain molecular and genetic insight into the 
evolution and current state of human traits, both in health and disease. 
1.2. Angiogenin: a peculiar angiogenesis-promoting RNase. 
1.2.1. Angiogenesis, the process of blood vessel formation 
Angiogenesis, the process of new blood vessel formation, is one of the earliest events in embryonic 
organogenesis [1]. In addition to providing the necessary oxygen and nutrients to developing organs, 
blood vessels are also responsible for delivering the trophic factors that are essential for organogenesis. 
The process of blood vessel formation in the embryo begins with angioblasts (endothelial precursors) 
that organize themselves into a primitive network of vascular capillaries – a process known as 
vasculogenesis (Figure 1A). It is noteworthy that at this early stage, a differentiation and commitment 
with venous and arterial cell lines is already observed. The angiogenesis step then proceeds with vessel 
sprouting and remodeling constituting a hierarchical network of large vessels and smaller ramifications. 
The newly formed endothelial cell (EC) channels become progressively covered with perycites (PC) and 
smooth muscle cells (SMC), strengthening the vase and allowing perfusion regulation. Mature vessels 
walls are comprised of endothelial and mural cell embedded in an extracellular matrix (ECM), the 
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precise constitution each being dictated by vessel type (Figure 1B) and location. The lymphatic system 
has a different developmental pathway involving transdifferentiation from veins (reviewed in [2]). 
Angiogenesis remains active after birth to support organ growth throughout development and into 
adulthood. At this stage most of the vessels remain quiescent and angiogenesis occurs mostly in 
ovarian cycling and at the placenta during pregnancy. However, ECs retain the ability to quickly respond 
to physiologic stimuli like hypoxia or inflammation, allowing the reactivation of angiogenesis in wound 
healing and tissue repair. The complexity of blood vessel formation, involving the structural and 
functional coordination of multiple cell types, is reflected at the molecular level where an intricate 
balance of stimulatory and inhibitory molecules is required to coordinate the process. These include 
integrins, angiopoietins, chemokines, junctional molecules and oxygen sensors, among many others 
(see [3] for a comprehensive review and compilation).  
 
Figure 1 – The development and cellular constitution of blood vessels 
(A) The formation of new blood vessels in the embryo starts with the formation a primitive vascular network by endothelial 
cell (EC) progenitors – vasculogenesis (1) that is followed by vessel sprouting and remodeling. The EC channels are 
progressively covered by perycites (PC) and smooth muscle cells (SMC) - Angiogenesis and arteriogenesis - to form the 
mature vascular network (2). Lymph vessels form mainly through vein transdifferentiation (adapted from [1]). (B) Nascent 
vessels are constituted by simple EC tubes (1) that mature and specialize into capillaries, veins and arteries. The distinct 
vessel wall compositions correlate with their functional and structural requirements (2-6) (adapted from [3]). 
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Considering its primordial importance and complex regulation, it is not surprising that imbalances in 
angiogenesis are involved in the pathogenesis of many diseases. Excessive angiogenesis is a hallmark 
of diseases like cancer and diabetic retinopathy (see supplemental table 1 for a comprehensive list of 
diseases), contributing to the growth of the abnormal tissue and destruction of the normal one, whereas 
in diseases like coronary heart disease and stroke (see supplemental table 2 for a comprehensive list of 
diseases) it is the deficient blood vessel growth that leads to reduced circulation and tissue death.  
The importance of angiogenesis in disease is well recognized, as it is one of the most heavily funded 
areas in medical research, with over US$4 billion invested in R&D of medicines to promote or reduce 
angiogenesis [4]. 
1.2.2. Angiogenin an angiogenic RNase 
Angiogenin (ANG), a potent in vivo inducer of angiogenesis, was first isolated in a systematic search 
for angiogenic factors secreted by human HT-29 colon adenocarcinoma cells [5]. Its increased 
expression was subsequently documented in different types of tumors and in several instances 
correlated with the disease progression and aggressiveness (reviewed in [6]). The use of antibodies [7-
10], antisense targeting [11] and inhibitors [12, 13] has proven useful in inhibiting the establishment, 
progression and metastasis of tumors in mouse models, thereby establishing ANG as a promising target 
for anticancer therapy. Furthermore, ANG was shown to have in vitro antimicrobial [14] and antiviral 
[15] effects, possibly participating in the innate immune defense. Recently, ANG mutations were 
described in amyotrophic lateral sclerosis patients [16], the second angiogenic factor to be implicated 
in this disease [17]. 
The human ANG gene comprises a single exon flanked by small UTRs and codes for a 14kDa 
polypeptide. The protein is synthesized with a 24 amino acid signal peptide that is cleaved to produce a 
mature form with 123 amino acids. Sequence analysis revealed its homology to the RNase A 
superfamily, where it was classified as RNase 5 [18, 19].  All members of this superfamily are secretory 
proteins that possess a classic hydrophobic signal peptide and have a molecular mass of 12–16 kDa in 
the mature, unglycosylated state. They present different degrees of ribonucleolytic activity and share 
three specific conserved residues — one lysine and two histidines — responsible for the catalytic 
mechanism (Figure 2) and six to eight cysteins that form three or four disulphide bonds. 
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ANG has three main distinctive functional features when compared to the superfamily archetype 
bovine RNase A: (1) the characteristic ribonucleolytic activity towards poly-, di- and cyclic nucleotides is 
104-106 lower and its enzymatic specificity is also different [20]; (2) the region between residues 58-70 
appears to constitute a ‘cell-binding site’, independent from the active site [21, 22], probably involved 
primarily in protein-protein interactions; and (3) the region 31-35 constitutes a nuclear localization 
signal (NLS) [23]. All of these features are essential to the angiogenic activity, as shown by directed 
mutagenesis experiments [23-26]. 
X-ray crystallography revealed the basis for angiogenin functional divergence [27, 28]. The three-
dimensional structures of RNase A and ANG share a similar kidney shaped fold (Figure 3A and B), 
however significant differences are observed in the C- and N-terminal and loop regions (Figure 3C). 
Furthermore, angiogenin presents only three of the four disulphide bonds of RNase A.  The active site of 
RNases can be divided in different subsites corresponding to the binding sites of the phosphate (P0-Pn), 
base (B0-Bn) and ribose (R0-Rn) moieties of each RNA nucleotide (Figure 4A). The most important ones 
are: (1) subsite P1, where scission of the P-O5’ bond occurs; (2) B1, where the 3’ base binds and (3) 
subsite where interaction with the 5’ base occurs. The superimposition of ANG and an RNase A uridine- 
2',3'- vanadate complex [29] active site regions shows that only the P1 subsite is well conserved in 
 
Figure 2 – General RNase A catalytic mechanism 
RNases A hydrolyze RNA in a two step reaction: (1) cleavage of the  P-O5´ bonds on the 3’ side of pyrimidines via a 
transphosphorylation mechanism to form 2’,3’-cyclic nucleotides, and (2) subsequent hydrolysis of the cyclic nucleotides to 
generate 3’ phosphate groups. The two catalytic histidines play reversible roles as general acid and general base and the 
lysine stabilizes the intermediate species. 
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angiogenin (Figure 4B). The most striking structural difference resides in the B1 subsite that is blocked 
by Gln117 and partly by Phe120. Angiogenin Gln117 occupies the same position as the uracyl moiety 
of the RNase A complex, forming interactions with Thr44 that mimic the ones established by this 
pyrimidine. The blocking of the B1 subsite is one of the reasons for the reduced ANG ribonucleolytic 
activity and, the inexistence of an alternative RNA conformation allowing its productive binding [30], 
implicates that a conformational change must occur for the catalysis to take place. 
The nuclear import of ANG was mapped in the position 31RRRGL35 [23], a region encompassing the 
c-terminal region of helix H2 and the beginning of loop L2. Alanine mutagenesis of Arg31 and Arg32 
reduced the efficiency of nuclear import whereas mutagenesis of Arg33 totally impaired it, suggesting 
Arg33 as the NLS critical site. The peptide RRRGL was shown to promote the nuclear import of albumin 
and to restore the import of angiogenin Arg33Ala mutant. More recently, ANG nuclear import was 
shown to be independent of the classic NLS-dependent pathway involving importins α/β and Ran 
GTPase [31], given its clear independence from cytosolic factors and ATP hydrolysis. Furthermore, ANG 
nuclear localization signal was shown to be unable to promote import of a large protein, β-galactosidase 
(476kDa), and the nucleoporin inhibitor WGA did not inhibit nuclear accumulation of ANG. Additionally, 
GTP hydrolysis (non-Ran dependent) was shown to promote both nuclear migration and nuclear 
retention of ANG. Based on these findings, a size-based mechanism was proposed, involving the 
nuclear import through passive diffusion and retention in the nucleus/nucleolus. The process would be 
regulated at both the cytoplasmic and nuclear sides, by means of binding to specific factors, mediated 
 
Figure 3 – Crystallographic structures of RNase A and Angiogenin 
(A) Structure of bovine RNase A highlighting the catalytic triad His12, Lys41 and His119. (B) Structure of human 
angiogenin highlighting the catalytic triad His13, Lys40 and His113; the nuclear localization signal (yellow) and the cell 
binding site (green). (C) Superimposed backbones (C-alpha trace) of bovine RNase A (red) and angiogenin (blue). 
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by the NLS region. The release from the cytosolic factor and the binding to the nuclear/nucleolar one 
would be GTP hydrolysis-dependent. 
A putative ‘cell-binding’ site was first mapped to the region between residues 60 and 68, as the 
proteolytic cleavage of peptide bonds 60/61, 67/68 or both, abolished the angiogenic activity without 
significantly affecting the enzymatic activity [21]. Mutation of Arg66 [32] and the substitution of ANG 
residues 58-70 for their RNase counterparts produced similar results [24]. Deamination experiments 
pointed out a second important residue, Asn61, and also a possible second region containing Asn109 
[22]. The ‘cell-binding’ site appears to be implicated in the binding to α-actin [33, 34], however the 
interacting region remains elusive in other identified interacting proteins as a putative 170 kDa receptor 
[35] or α-2-actinin [36].  
Despite the vast number of functional studies, a consilient pathway for angiogenin-induced 
angiogenesis remains elusive. Angiogenin has been shown to activate both ECs and SMCs, inducing 
several different responses like cell migration and invasion [37], proliferation and the formation of 
tubular structures [38]. It has been reported to trigger several signaling pathways: ERK1/2  [39] and 
protein kinase B/Akt [40] in human umbilical vein ECs or SAPK/JNK in human umbilical artery SMCs 
[41]. Exogenous angiogenin undergoes nuclear translocation [25], an essential step to its function [25, 
42] that occurs through a microtubule network and lysosomal processing independent pathway [43]. 
Once in the nucleus it binds to DNA thereby enhancing rRNA transcription [44-46], a limiting step for 
protein translation and therefore cellular responses (Figure 5).  
Recently, EC endogenous angiogenin was shown to be required for angiogenesis induced by other 
angiogenic factors like the fibroblast growth factor (FGF), epidermal growth factor (EGF) and vascular 
 
Figure 4 – Comparison of RNase A and Angiogenin active sites 
(A) General nomenclature for the subdivision of RNase A active sites. (B) Superimposed structures of RNase A (red) in 
complex with inhibitor uridine- 2',3'- vanadate (UVan, green) and angiogenin (blue) showing the P1 and B1 subsites (only 
the uracyl fraction is shown for the B1 subsite). Broken lines represent hydrogen bonds of the RNase A-UVan complex. 
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endothelial growth factor (VEGF) [47]. The downregulation of angiogenin by siRNA or antisense reduced 
angiogenesis even in the presence of high concentrations of these factors. Angiogenin-regulated rRNA 
transcription can therefore constitute a cross-road in angiogenesis induced by the different factors. 
1.2.3. The dynamic evolution of the RNase superfamily 
The RNase superfamily appears to be vertebrate-specific, since no RNase genes have so far been 
described in invertebrates. In vertebrates, the reduced number of RNases in non-mammalian 
vertebrates, like birds or fish, contrasts with the 13-20 highly divergent members in mammals. Non-
mammalian RNases have an angiogenin-like structure, although their angiogenic activity has yet to be 
examined or detected. Based on this evidence, Cho et al. [48] proposed that this superfamily arose in 
early vertebrate evolution with an ANG-like ancestral that underwent expansion before the divergence 
between placental and marsupial mammals. This expansion would have been followed by a process of 
differential gene duplication and retention between different orders of the placental mammals, resulting 
in the present inter-species diversity of the RNase superfamily [49] (Figure 6). 
Positive (diversifying) selection had a strong influence in the RNase evolutionary pathway: eosinophil 
RNases, EDN and ECP, are among the most rapidly evolving coding sequences in primates [50, 51], as 
are the paralogous rodent eosinophil associated ribonucleases (EARs) [52]. ANG genes suffered a rapid 
 
Figure 5 – General model for angiogenin-induced angiogenesis 
(1)  Exogenous angiogenin is internalized and migrates to the nucleolus where it has been shown to increase rRNA 
translation. (2) Exogenous angiogenin is also able to activate several different signaling pathways in endothelial (EC) and 
smooth muscle cells. The role of identified protein interactions in mediating the internalization, nuclear migration or 
activation of signaling pathways is still elusive, as is the cross-talk between the two paths. Independently of the underlying 
mechanism, angiogenin induces several cellular responses that ultimately promote angiogenesis. 
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expansion in rodents – 6 genes and 3 pseudogenes in the mouse genome, 2 genes in the rat genome – 
as the result of positive selection and gene sorting. ANG has also been shown to be under the effect of 
diversifying selection in primates [53]. All primate species analyzed thus far possess a single gene for 
ANG except for Pygathrix nemaeus (Asian Douc Langur), in which the ANG gene appears to have 
pseudogenized [54]. 
1.3. Identifying and analysing positive selection signatures 
1.3.1. The Neutral Theory of Molecular Evolution  
The genetic variability arising from several mechanisms inherent to the genome, like mutations and 
recombination, constitutes the basis for evolution by natural selection. Depending on the effects these 
mutations have on the fitness of the individual, they can be broadly classified as adaptative 
(advantageous), deleterious or neutral (having no effect in fitness). In order for natural selection to act 
on a population these genetic variations need to be inheritable, otherwise the fitness differences 
provided will not be transmitted to the following generations.  
The fixation of adaptative mutations in evolving populations was a central point of Darwin’s theory 
on the origin of species through natural selection and until the late 1960’s, most evolutionary biologists 
believed that the majority of a population variations were maintained by balancing selection, a form of 
selection through which two or more alleles for the same locus are maintained in a population. Under 
 
Figure 6 – Mammalian RNase superfamily evolutionary history 
Major evolutionary changes in the RNase superfamily genes mapped on the mammalian phylogeny (adapted from [49]). 
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this view, most genes would have to be monomorphic; otherwise the imposed genetic load would be far 
too great. However, the increasing availability of protein sequences from several mammals prompted 
studies that progressively changed paradigms: (1) Zuckerkandl and Pauling [55] observed that the 
number of amino acid differences between pairs of mammalian species was roughly proportional to the 
phylogenetic distance between them, as accessed from fossil records, leading them to propose a 
constant rate for amino acid substitution with time – the molecular clock theory; (2) protein 
electrophoresis studies by Harris [56] and Hubby and Lewontin [57] demonstrated a widespread 
presence of polymorphisms within populations. Both observations were highly controversial, because of 
the difficulties to conceive an evolutionary mechanism allowing a constant rate of substitution and to 
imagine how natural selection could maintain such high levels of polymorphisms within populations as 
it would have an unbearable ‘cost of selection’ [58].    
A conciliating solution came from the neutral theory of molecular evolution formulated 
independently by Kimura, King and Jukes [59, 60] – if the majority of amino acid substitutions were 
selectively neutral, then substitution would occur at a fairly constant rate and high levels of 
polymorphism could be maintained, as the selective cost would be low. In his pioneering work, Kimura 
[59] used the hemoglobin, cytochrome c and triosephosphate dehydrogenase sequences from several 
primate and other mammalian species to estimate the rate of nucleotide substitution in two different 
opposing conditions: selection and neutrality. He concluded that this rate was very high and that it 
could only be conciliated with the limits imposed by the ‘cost of selection’ if one assumed that the 
majority of de novo mutations were nearly neutral in terms of natural selection. He supported the 
viability of this assumption by well-designed mathematical calculations and finally pointed out the great 
importance of genetic drift as a shaping force for the genetic structure of biological populations. Soon 
after, in their very provocative paper “Non-Darwinian evolution” King and Jukes [60] independently 
reached similar conclusions, after a far more extensive analysis of DNA and protein sequences. The 
Neutral Theory of Molecular Evolution, as revised by Kimura in 1983 [61], states that the majority of 
polymorphisms and substitutions represent the random change in frequency of neutral alleles by 
genetic drift, rather than being a product of different types of selection. Polymorphisms are seen as 
transient entities waiting either to be fixed or eliminated by genetic drift. Negative selection plays a role 
in eliminating deleterious mutations arising in regions of functional constraint whereas positive and 
balancing selections are considered rare events. One of the important properties of the neutral model of 
evolution is that it allows for theoretical predictions regarding the rate of mutation and evolutionary 
parameters:  
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I. The degree of polymorphism within a species is a function of the mutation rate and 
population size according to the following relation:  
4
(1 4 )
N
H
N
μ
μ= +   (1.1) 
where H represents the expected heterozygosity, N the population size and μ is the mutation 
rate per locus [62]. 
II. The rate at which mutational differences accumulate as two species diverge (i.e. the 
substitution rate) is the same as the rate at which neutral mutations arise (μ) [63].  
III. The expected frequency of alleles in a sample is a function of the population and sample 
sizes [64]. 
The selectionist/neutralist debate of the 70’s and 80’s progressively faded (reviewed in [65]) to give 
rise to a more complex view, where both positive and negative selection appear to carve their signatures 
in the genome. However, the neutral theory has gained a central role in the evolutionary analysis of 
DNA sequence variations, due mostly to its simplicity and predictive scope, allowing it to be readily 
applied as a null hypothesis against which to test for selection. 
1.3.2. Analytical methods to detect natural selection in DNA sequences 
A large number of methods to detect natural selection have been developed over the last decades 
that can be grouped in two broad categories based on the type of analysis performed: (1) tests based 
on the frequency or level of variability of sites, (2) tests based on the divergence or variability between 
different classes of mutations (Table 1).  
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All these statistical tests explore the analytical tractability of the neutral theory and, by comparing its 
predictions to the observed data they can detect departures from neutrality. In this sense, this type of 
genetic data-based analysis of natural selection is more accurately designated as neutrality tests, since 
they test the null hypothesis of neutrality in sequence evolution [74].  
Each method has its particular assumptions, the violation of which can lead to the rejection of the 
null hypothesis, even in the absence of natural selection. The methods on the first category are strongly 
dependent of demographic assumptions, admitting a panmitic, non-subdivided population whose size 
as remained constant for a sufficient time to erase the signatures of any demographic effects of the 
past – a state of equilibrium. A population expansion or bottleneck can cause departures from 
neutrality-equilibrium that can be mistakenly interpreted as positive or balancing selection. On the other 
hand, the methods on the second category, in particular MK and dN/dS, are quite robust to 
demographic effects, since they analyze two classes of mutations in a single locus and the demographic 
effects are expected to impact both classes similarly [75, 76]. This robustness, in conjunction to its 
computational implementation in several software packages, has made the dN/dS (ω) method one of 
the most used methods to analyze natural selection in DNA sequences. 
Table 1 – Commonly used tests to detect natural selection  
 
Name Used to compare Reference 
1. Tests based on allelic distribution and/or level of variability 
Tajima’s D The number of nucleotide polymorphisms with the mean pairwise 
difference between sequences 
[66] 
Fu and Li’s D, D* The number of derived nucleotide variants observed only once in a 
sample with the total number of derived nucleotide variants 
[67] 
Fu and Li’s F, F* The number of derived nucleotide variants observed only once in a 
sample with the mean pairwise difference between sequences 
[67] 
Fay and Wu’s H The number of derived nucleotide variants at low and high frequencies 
with the number of variants at intermediate frequencies 
[68] 
2. Tests based on comparisons of divergence and/or variability between different classes of 
mutations 
dN /dS  
Ka /Ks 
The ratios of non-synonymous and synonymous nucleotide 
substitutions in protein coding regions 
[69, 70] 
HKA 
Hudson–Kreitman–
Aguade 
The degree of polymorphism within and between species at two or 
more loci 
[71] 
MK 
McDonald–Kreitman 
The ratios of synonymous and non-synonymous nucleotide 
substitutions in and between species 
[72] 
 
 
(Adapted  from  [73]) 
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1.3.2.1. The non-synonymous to synonymous ratio method 
The dN/dS (ω) method consists of a comparison of non-synonymous (amino acid-changing, dN) 
and synonymous (silent, dS) substitution rates in protein coding DNA sequences: 
ω = /dN dS  (1.2) 
The ratio ω is a measure of the difference between the two rates – if an amino acid change is neutral, 
its rate of fixation will be similar to the one for synonymous substitutions and so ω=1. Conversely, if the 
mutation is deleterious its rate of fixation will be smaller that the one for synonymous substitutions and 
the ratio will be ω<1. Finally, if the substitution is advantageous its rate of fixation will be higher than 
the one for synonymous substitutions and so ω>1 [77]. 
ω
ω
ω
< < ⇒⎧⎪ = = ⇒⎨⎪ > > ⇒⎩
( 1) change is deleterious (purifying selection)
( 1) change is neutral
( 1) change is advantageous (diversifying selection) 
dN dS
dN dS
dN dS
(1.3) 
Initially, dN/dS  ratio estimations relied on approximate methods, developed in the 1980s and early 
1990s (for example methods by Miyata and Yasunaga [79], Nei and Gojobori. [70] and Li et al. [69]) 
These approaches have three main steps in common: counting of synonymous and non-synonymous 
 
Figure 7 – DNA mutation: Transitions and transversions 
Nucleotide base transitions involve purine-purine or pyrimidine-pyrimidine conversions whereas transversions involve purine-
pyrimidine or pyrimidine-purine changes. Since for each substitution there is only one possible transition against two 
possible transversions, these would be expectable to be twice as frequent. However, in mammalian genomes the transition 
rate is higher than the transversion rate. Several factors may account for this unexpected difference – the more conservative 
nature of transversions at the third ‘wobble’ position in the encoded peptide sequence (coding sequences), the high 
frequency of C-T transitions due to the instability of cytosine residues in CpG dinucleotides (coding and non-coding 
sequences) and differential repair of mispaired bases by the distinct DNA polymerases [78]. 
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sites in the two sequences, counting of synonymous and non-synonymous differences between the two 
sequences, and correcting for multiple substitutions at the same site. However, only estimates of the 
ratio can be obtained, since they use ad hoc calculations that can not be justified. Furthermore, they fail 
to take in account important features of DNA sequence evolution like the transition-transversion rate 
bias (Figure 7) and differential nucleotide or codon usage.  
Approximate methods were progressively surpassed by more powerful approaches. Maximum 
likelihood (ML) methods, pioneered in 1994 by Goldman and Yang [80] and Muse and Gaut [81], 
consider the codon as the unit of evolution and are based on explicit models of codon substitution. 
Admitting two codons, i and j (i≠j), the substitution rate from i to j is given by: 
π
κπ
ωπ
ωκπ
⎧⎪⎪⎪= ⎨⎪⎪⎪⎩
j
j
0,  if the 2 codons difer at >1 one position
,  for synonymous transversions
, for synonymous transitions
,  for nonsynonymous transversions
, for nonsynonymous transitions 
j
ij
j
q  (1.4) 
Parameter jπ  is the equilibrium frequency of codon j and κ is the transition/transversion rate. Given 
this matrix, the transition probability matrix over time t is calculated by: 
{ }= =( ) ( ) QtijP t p t e  (1.5) 
Where ( )ijp t  is the probability of codon i becoming codon j after the time t. Likelihood calculations on 
a phylogeny involve summing over all possible codons in ancestral sequences (interior nodes of the 
tree). All the parameters in the model (κ, ω, t) are directly estimated from data by maximum likelihood 
and are used to calculate dN and dS. The great advantage of this method is that all the difficult tasks 
are obtained from the probability theory in a single step: estimation of model parameters, correction for 
multiple hits and weighting pathways of change between codons.  
The first ML methods assumed a single ω ratio for all sites in a given sequence and therefore 
positive selection would only be detected if the average ω for all sites was above one. This was a quite 
conservative approach, as many sites might be under purifying selection due to functional constraint 
and have a ω value close to zero. Nielsen and Yang [82] extended these methods to allow ω variation 
among sites based on two simple models. The null model M1 (neutral) assumes a class of conserved 
sites (ω=0) and a class of neutral sites (ω=1). The alternative model, M2 (selection), contains a third 
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class of sites with ω estimated from the data. If the M2 model fits the data significantly better than M1 
and the ω value for the third class in M2 is higher than 1, then there is evidence for positive selection at 
some sites. The significance of fitness can be assessed through a likelihood ratio test (LRT) comparing 
the likelihood score of the two models: 
= × −2 (ln 1 ln 2)LRT L L  (1.6) 
Since this LRT follows a chi-square distribution, the statistical significance of the difference between the 
likelihoods for the two models can be obtained from a comparison with a χ2 distribution with a number 
of degrees of freedom equalling the parameter difference between the two models. Several more 
realistic models were latter implemented by Yang and Nielsen [83], including the beta distribution that 
assumes a flexible null model with 0<ω<1 (M7 beta), which can be compared with an alternative 
selection model that adds an additional class of sites with ω estimated from the data (M8 beta).  
A significant LRT demonstrating the best fit of a positive selection model is only an indication that 
the sequence in analysis has sites under positive selection; it does not provide any kind of information 
on their identification. This second, far more challenging step, can be accomplished through an 
Empirical Bayes (EB) approach to calculate the posterior probability (PP) that a given site comes from 
the class with ω>1. Sites presenting a PP above a defined cut-off (generally P>95%) are inferred to be 
under positive selection. Initial empirical Bayes approaches used maximum likelihood estimates of 
parameters (MLE), such as the proportions and ω ratios for the site classes, without accounting for their 
sampling errors and were therefore designated as Naïve Empirical Bayes (NEB). Estimation of MLEs is 
reliable in large datasets, however, in smaller datasets MLEs may present with large sampling errors, 
thus rendering the NEB calculations of posterior probabilities unreliable. To tackle this limitation, a 
more robust method was developed, accommodating the uncertainties in the MLEs of parameters in the 
ω distribution, designated Bayes Empirical Bayes (BEB) [84]. This approach was shown to be more 
reliable, in both small and large data sets, and also to have a good power for identifying individual sites 
under positive selection, especially in large data sets or with strong selective pressure. These methods 
were implemented in PAML, a program package for phylogenetic analysis by maximum likelihood 
developed by Yang [85].   
The main ML ‘competitors’ are maximum parsimony methods, independently developed by Fitch et 
al. [86] and Suzuki and Gjobory [87], infer substitutions using maximum parsimony to reconstruct 
ancestral sequences. The excess of non-synonymous substitutions is tested independently for each site. 
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The method developed by Fitch et al. [86] first averages the dN/dS  ratio across the sequence and then 
compares the ratio for each site against this average, while the Suzuki and Gjobory [87] method 
independently compares the dN/dS  ratio at each site against the neutral expectation of ω=1. Maximum 
parsimony is implemented in the ADAPTSITE program package developed by Suzuki [88].  
Several individual and comparative analyses of the previously described methods have been 
published, with rather contradictory results. Anisimova et al. [89] focused on the ML method, 
concluding that it had a good power and accuracy if used for medium and large sized sample, losing 
resolution when only a few highly similar sequences were used or when selection was weak. Upon the 
publication of their parsimony method, Suzuki and Gojobori  [87] analyzed its performance and 
concluded that it had low false-positive rate and that its power increased with increasing branch lengths 
and the strength of selection. Soon after, Suzuki and Nei [90, 91] performed two studies comparing 
parsimony and ML methods in the prediction of positive selected sites, concluding that parsimony was 
more robust and conservative whilst ML produced numerous false positives. In the first study, they used 
a dataset of the human leukocyte antigen (HLA) alleles and evaluated the performance of methods by 
the number and location of amino acids inferred to be under positive selection in the antigen 
recognition site (ARS). They found several issues with the ML and argued that it was inferior to 
parsimony. Curiously, using a similar HLA dataset Yang and Swanson [92] found biological significant 
results with ML.  
In a recent report aiming to end this controversy, Wong et al. [93] conducted a comprehensive 
simulation to determine the power and reliability of both methods. They concluded that ML method did 
not generally lead to an excess of false-positives when the models were correctly applied and the 
optimization problems solved. Furthermore, they demonstrated that the problems with ML presented in 
the previous works by Suzuky and Nei [90, 91] were most likely caused by problems in the simulation 
or optimization as a result of the PAML version used. In contrast, they verified that the ADAPTSITE 
software (parsimony-method) was unable to identify positive selection in almost all datasets used and 
that it should only be used in large datasets with many sequences. Finally, the authors highlighted the 
fact that predicting positive selection is a very complex statistical problem, especially when the ω value 
is low. None of the softwares could reliably distinguish sites with ω=1 from sites with ω=1.5 and 
therefore one must be cautious when drawing conclusions on positive selection based ω values only 
marginally higher than 1.  
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The analysis of positive selection using maximum likelihood is a sensitive method, however, once 
selection is detected, it provides little information on the causes or driving forces of selection. 
Furthermore, a dN/dS ratio inferior to one does not guarantee that positive selection has not happened, 
since even a single amino acid replacement can be adaptative, if it leads to a protein that is 
biochemically superior to its ancestral. This is particularly important in the case of conserved proteins. 
These limitations have been addressed in methods of evolutionary analysis based on amino acid 
properties. 
1.3.2.2. Amino acid properties-based methods 
Many of the amino acid physicochemical properties that dictate for protein structure and function 
have been shown to correlate with the evolution of the genetic code, the amino acid composition of 
polypeptides, and the rates of amino acid replacement. As a result, codons with similar sequences 
generally encode for amino acids with similar physicochemical properties [94]. Based on this premises 
McCraken and McClean [95] analysed the molecular adaptation of Cyt-b functional domains in 
Geomyidae and Cetartiodactyla, using six amino acid properties known to correlate with the rates of 
amino acid replacement - composition of the side chain, polarity, molecular volume, polar requirement, 
hydropathy and isoelectric point. To estimate the selective pressures on the evolution of Cyt-b, they first 
compared the goodness of fitness between the observed changes in amino acid properties and an 
expected distribution based on the assumption of a completely random amino acid replacement under 
the neutral theory. They then compared the number of inferred physicochemical changes in four 
magnitudes: conservative, moderate, radical, and very radical with the number of possible evolutionary 
pathways using a normal distribution (χ2) to obtain relative measures (z-scores) of the selective 
influence on each amino acid property. The obtained goodness of fitness-score (GF-score) and the set of 
three z-scores represent the selective pressure in a given region, the intensity given by the GF-score and 
the direction of selection by the z-score.  
This methodology was adopted and extended to other properties by Woolley et al. in the software 
TreeSAAP [96]. This program uses calculations of expected random distributions of possible amino acid 
changes based on fixed differences between residues given a particular physicochemical property. By 
comparing expected distributions with changes inferred from well corroborated phylogenetic trees, 
detection of significant deviations from neutral expectations is possible (see also Figure 8 in material 
and methods). These deviations are categorized and, given their expected higher impact in fitness, the 
changes falling in the most radical categories correlate with positive selection.   
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Bearing in mind the important effects that positive selection has had in the evolution of angiogenin 
(and the RNase A superfamily in general) and the biological and clinical relevance of this protein, in this 
work I aimed at: 
1. Analyzing positive selection on the primate ANG gene using: (1) a gene level evaluation of 
the non-synonymous/synonymous ratio (dN/dS) and (2) a protein level evaluation of radical 
changes in amino acid properties.  
2. Pinpointing the amino acid sites with a higher probability for being under positive selection. 
3. Assessing the impact of sites under positive selection in the structure and function of 
primate ANG. 
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3.1. Sequence data 
ANG coding sequences were retrieved from GenBank for 14 different species, representative of the 
two main branches of the simian primates: Platyrrhini (new world monkeys) and Catarrhini (old world 
monkeys and hominids). Reference sequences were available for Homo sapiens and Pan troglodytes, 
the remaining primate sequences had been previously published [53, 54] (Table 2). In all alignment 
and figures, the names of the species were abbreviated as the genus plus the first initial of the specific 
epithet. The Homo sapiens amino acid sequence is used as reference in all tables and corresponds to 
the coding sequence numbering minus the 24 amino acids of the signal peptide. 
3.2. Sequence alignments and phylogenetic trees 
A protein based coding sequence alignment was constructed by aligning translated protein 
sequences using the Clustal W algorithm [97] with default settings, in MEGA version 3.1 [98] and 
retrieving the corresponding DNA sequences. Gaps were removed from analyses. Phylogenetic trees 
were constructed using three distinct algorithms: neighbour-joining (NJ) [99] with 1,000 bootstrap 
Table 2 – Species used in this study and sequence reference numbers. 
Common Name  Species  
GenBank 
Reference 
Human  Homo sapiens  NM_001145 
Chimpanzee  Pan troglodytes  NM_001009159 
Gorilla  Gorilla gorilla  AF441662 
Orangutan  Pongo pygmaeus  AF441663 
Baboon  Papio hamadryas  AF441666 
Rhesus macaque  Macaca mulatta  AF441667 
Vervet monkey  Cercopithecus aethiops  AF441664 
Talapoin monkey  Miopithecus talapoin  AF441665 
Tonkin snub-nosed monkey  Pygathrix avunculus    AY221132 
François’s leaf monkey  Trachypithecus francoisi  AY221129 
Mantled guereza  Colobus guereza  AY221128 
South American squirrel monkey  Saimiri sciureus  AF441670 
Cotton-top tamarin  Saguinus oedipus  AF441668 
Northern night monkey  Aotus trivirgatus  AF441669 
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replicates [100] in MEGA version 3.1; Maximum likelihood (ML) in Paup 4.0b10 [101] using the 
PaupUp graphical interface [102] and Bayesian analysis (BY) in MrBayes 3.1.2 [103]. For ML the best 
substitution model was evaluated using Modeltest 3.7 [104] that according to corrected Akaike 
information criterion (AICc) determined SYM + G as the best-fit model. The best phylogenetic tree was 
determined using heuristic search with nearest-neighbour interchange (NNI) and nodes support was 
evaluated by bootstrapping with 1,000 replicates. For Bayesian analysis the best substitution model 
was evaluated through MrModelTest [105], a modified version of David Posada's Modeltest 3.6 
rewritten to compare all of the 24 models that can be implemented in MrBayes version 3, which also 
selected SYM+G as the best-fit model according to AICc. 
3.3. Evolutionary analyses  
Alignments and the NJ/ML/BY trees were used for posterior molecular evolution analyses. Evidence 
for positive selection on ANG was first evaluated using likelihood ratio tests (LRTs) through the CODEML 
algorithm of the PAML 3.14b package [106]. These tests compare the fit of two nested, site specific 
models, to the data, a neutral model that does not admit positive selection (ω<=1) and a more general, 
alternative model that admits positive selection (ω>1). The one ratio model (M0) and three pairs of site 
specific were used, as suggested in the user’s guide [107]:  M1a (NearlyNeutral) versus M2a 
(PositiveSelection); M7 (Beta) versus M8 (Beta&ω) and M8a(Beta&ωs=1) versus M8 (Beta&ω). The 
level of significance for these LRTs was calculated using a chi-square (χ2) approximation given that twice 
the difference of log likelihood between the models (2ΔlnL) will asymptotically have a χ2 distribution, 
with a number of degrees of freedom corresponding to the difference of parameters between the nested 
models. Due to complications with non-estimable parameters, the following degrees of freedom were 
used, as they are expected to be conservative [107]: M1a vs M2a df=2; M7 vs M8 df=2; M8a vs M8 
df=1. Similar results were obtained for all methods of tree reconstruction, reflecting PAML robustness in 
respect to the phylogenetic tree used. The Bayesian posterior probabilities for each site are directly 
calculated for the models admitting selection (M2a and M8) and were retrieved for the BEB 
methodology, given its higher accuracy when compared to NEB. 
A protein level analysis was performed using TreeSAAP 3.2 [96]. This program calculates the 
goodness-of-fit between an observed distribution of changes in amino acid physiochemical properties 
and an expected distribution admitting that each amino acid replacement is equally likely under 
selective neutrality. These are analyzed based on the ancestral reconstruction inferred from the coding 
sequence alignment and corresponding phylogenetic tree using the CODEML algorithm.  
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The range of changes in amino acid properties is divided in eight magnitude categories (Figure 8) and 
we considered positive selection for the more radical variations: +6, +7 and +8. The number of 
properties under positive selection per site was determined by adding the results per branch. All the 31 
properties in TreeSAAP were used and categorized in three groups: chemical, structural and others 
(Table 3).  
Table 3 – TreeSAAP properties and their categorization 
Property Name  Symbol  Category 
 
Buriedness  Br  Chemical 
Chromatographic index  RF  Chemical 
Equilibrium constant of ionization -COOH  pK'  Chemical 
Hydropathy  h  Chemical 
Isoelectric point  pHi  Chemical 
Long-range non-bonded energy  EI  Chemical 
Normalized consensus hydrophobicity  Hnc  Chemical 
Polar requirement  Pr  Chemical 
 
Figure 8 – Flowchart for TreeSAAP analyses 
(1) Nucleotide characters are optimized onto a well-corroborated phylogenetic tree to infer amino acid replacement events; 
(2) observed amino acid replacements are analyzed in the context of the several physicochemical properties to determine 
the magnitude classes (c1–c8) of change; (3) the codon compositions of the extant DNA sequences are analyzed in terms 
of relative frequencies of magnitude classes of evolutionary pathways for each amino acid property; and (4) percent 
difference between expected and observed mean changes [33] and goodness-of-fit (assuming a χ2-distribution) of observed 
to expected distributions [32] are calculated for three scales, and the hypothesis of equality between contiguous proportions 
(p1–p8) of observed substitutions to expected evolutionary pathways is tested (using a normal distribution) for each 
property (probabilities denoted with * for p < 0.05, and ** for p < 0.01). 
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Property Name  Symbol  Category 
Polarity  p  Chemical 
Refractive index  μ  Chemical 
Short and medium range non-bonded energy  Esm  Chemical 
Solvent accessible reduction ratio  Ra  Chemical 
Surrounding hydrophobicity  Hp  Chemical 
Thermodynamic transfer hydrophobicity  Ht  Chemical 
Total non-bonded energy  Et  Chemical 
Composition  c  Other 
Molecular weight  Mw  Other 
α−helical tendencies  P  Structural 
Average number of surrounding residues  Ns  Structural 
β-structure tendencies  P  Structural 
Bulkiness  BI  Structural 
Coil tendencies  Pc  Structural 
Compressibility  K0  Structural 
Helical contact area  Ca  Structural 
Mean RMS fluctuation displacement  F  Structural 
Molecular volume  Mv  Structural 
Partial specific volume  V0  Structural 
Power to be at the C-terminal of an α-helix  αc  Structural 
Power to be at the middle of an α-helix  αm  Structural 
Power to be at the N-terminal of an α-helix  α  Structural 
Turn tendencies  P  Structural 
 
One of the important steps of the former methods is ancestral reconstruction, i.e. the reconstruction 
of the sequences for extinct ancestrals (interior nodes of the phylogenetic tree) based on the current 
sequences. This is directly performed by the CODEML algorithm that uses a maximum-likelihood 
analysis of branch lengths and the substitution pattern to determine the most probable ancestral 
sequence [108, 109]. 
The conservation of the sites detected under selection throughout the RNase A superfamily was 
tested using the ConSurf webserver [110]. This program calculates conservation scores for sites in a 
protein, based on a sequence alignment and phylogenetic trees, through an empirical Bayesian 
approach. Clustal-W alignments of the 14 primates sequences used in this study and a pool of 168 non-
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angiogenin RNase sequences (obtained by 6 psi-blast iterations using the Homo sapiens sequence as 
query) were submitted to the server. The human ANG structure (PDB: 2ANG) was used as reference 
and the phylogenetic tree was the one generated by ConSurf. Confidence intervals for the conservation 
scores estimations are calculated and when the number of sequences is small, the confidence interval 
tends to be large. Amino acid positions that are assigned with too large confidence intervals are 
considered to be below the confidence cut-off.  
3.4. Structural analysis and homology modeling  
The 2.0Å X-ray crystallographic structure of human ANG, retrieved from the Protein Databank as 
2ANG [28] was used for structural analysis and homology modeling. Visualization and editing of the 
structure was performed using pyMOL (DeLano Scientific, San Carlos, CA, USA).  
Homology modeling was performed for ancestral and current sequences, with the human ANG 
structure as template, using Swiss-model [111] through the project mode in DeepView/Swiss-pdb 
viewer. Briefly, the PDB coordinates file (without waters and heteroatoms) and the sequence to model 
were loaded in DeepView and the resulting sequence alignment manually corrected. The subsequent 
project was then submitted to the Swiss-Model server for automated model generation and energy 
minimization, thereby producing the final optimized model. The model quality was assessed by What-
Check [112] through Swiss-Model. Furthermore, given the high degree of homology between 
sequences, the quality of the models is expected to be high and depending mostly on the quality of the 
alignment (reviewed in [113]). 
The surface exposure of amino acids was assessed using GETAREA 1.1 [114] web interface. This 
program performs analytical calculation of solvent accessible surface area (ASA) for a PDB file based on 
the ratio between the side-chain surface area and the "random coil" value per residue. The "random 
coil" value of a residue X is the average solvent-accessible surface area of X in the tripeptide Gly-X-Gly in 
an ensemble of 30 random conformations. Residues are considered to be solvent exposed if the ratio 
value exceeds 50% and to be buried if the ratio is less than 20%. 
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4.1. Phylogenetic analyses 
A protein based alignment of coding sequences was produced for the 14 primate species (see 
methods 2.1, table 2). Given the high degree of homology the alignment was straightforward, with a 
single gap introduced in non-hominoid species that have 122 amino acids instead of 123 (Figure 9).  
Neighbour-Joining (NJ), maximum-likelihood (ML) and Bayesian (BY) tree reconstructions of the 
primate ANG coding sequences (see Table 2) presented similar overall topologies. ML and BY trees 
were topologically identical, the main difference relatively to the NJ tree being the unresolved 
Homo/Pan/Gorilla trichotomy and the positioning of Miopithecus talapoin. Overall tree topologies were 
mostly coherent with the accepted phylogeny of primates. The small differences detected are not 
surprising as a gene tree does not necessarily reflect the species tree [115]. 
 
Figure 9 – Amino acid alignment for primate species analysed 
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4.2. Positive selection analyses 
I first analyzed primate ANG genes for signatures of positive selection using PAML [106]. The first 
model tested, M0, a very stringent model given that the ω ratio is averaged along the whole gene, 
provided good support for positive selection in the primate ANG gene with a ω = 1.29. Three pairs of 
nested models were also tested, allowing ω variation between codons: one admitting no positive 
selection (restricting ω≤1) and another admitting positive selection (M1a-M2a, M7-M8, M8a-M8). The 
best fitting models were determined through likelihood-ratio tests, which showed that both M2a and M8 
presented a significantly better fit to the data then their neutral counterparts M1a, M7 and M8a (Table 
4). The slightly more conservative model M2a detected 41% of sites under positive selection (ω=3.10) 
whereas M8 detected 49% of sites under positive selection (ω=2.88), indicating with a high degree of 
confidence that positive selection is acting at the ANG gene. These results were consistent across all the 
tree reconstruction methods used and are presented in Table 5 for the NJ method.  
Posterior Bayesian analysis through a BEB methodology [84] allowed the determination of several 
amino acid sites under positive selection. M2a detected four sites with a PP above 0.95 and four above 
0.99, whilst M8 detected nine sites above 0.95 and seven above 0.99. Either of the models detected 
several other sites with a PP above 0.9. Similar results were obtained across all tree topologies, with the 
exception of site 52 that only had a strong support in the NJ topology.  
 
Figure 10 – Phylogenetic tree for the primate ANG sequences used. 
The neighbour-Joining phylogenetic tree is presented and the bootstrap values for different methodologies are indicated 
above each branch (NJ/ML/BY). The symbol (*) indicates the positions where distinct topological arrangements were 
observed between methods. 
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Table 4 – PAML parameters and likelihood-ratio tests 
Model Parameters lnL  2ΔlnL (LRT) 
 
M0 ω = 1.2934 -1632.9  na 
 M1a vs M2a 
M1a 
p0 = 0.38665 
p1 = 0.61335 
 ω0 = 0.00000 
ω1 = 1.00000 
-1614.8 
M2a 
p0 = 0.40009 
p1 = 0.18886 
p2 = 0.41105 
ω0 = 0.00000 
ω1 = 1.00000 
 ω2 = 3.09729 
-1601.2 
 
 
27.3 
(p <0.0001) 
   
M7 
p = 0.00750 
q = 0.00500 
-1614.8 
 M7vs M8 M8a vs M8 
M8 
p0 = 0.51176 
p1= 0.48824 
p = 0.19739 
q = 1.36510 
 ω = 2.88352 
-1601.4 
M8a 
p0 =  0.38665 
p1=   0.61335 
p =  0.00500 
q = 69.77288 
ω = 1.00000 
-1613.4 
 
 
26.9 
(p <0.0001) 
26.9 
(p <0.0001) 
 
Since the M1a-M2a LRT is more conservative and the M7-M8 LRT is prone to false positives [116], 
we adopted an empiric threshold to consider candidate sites under positive selection: a PP above 0.95 
for M8 and simultaneously above 0.90 for M2a. Fifteen sites were above the defined threshold (Table 
5).  
Validation of these results was further obtained using a complementary protein level approach 
 
Figure 11 – Number of TreeSAAP properties under positive selection per site 
A Plot representing the total number of properties under positive selection after adding the branch results for each site. Full 
black bars indicate the sites detected under positive selection on the PAML analysis 
 
Chapter 4 
STRUCTURAL AND FUNCTIONAL IMPLICATIONS OF POSITIVE SELECTION ON THE PRIMATE ANGIOGENIN GENE 30 
implemented in TreeSAAP [96]. The distribution of the number of properties under positive selection 
per site is presented on Figure 11 and the results per branch for relevant sites are presented in Annex 
II. Based on the results, an empirical threshold of six properties with radical changes was adopted for 
considering support for previous candidate sites. 
Of the 15 PAML sites, five had a number of properties above the defined threshold (Table 5), of 
which site 66 had the highest number of properties under selection (n=16). In order to facilitate 
posterior analyses, a categorization was introduced: sites that found support in both PAML and 
TreeSAAP were designated as type I whereas sites that found only support in PAML were designated as 
type II. 
Table 5 – Sites under positive selection on the primate ANG gene 
Sites 
 
 
PAML 
ω / PP (BEB)   TreeSAAP properties 
Co
do
n 
Am
in
o 
ac
id
 
 M2a M8  
To
ta
l 
Chemical Structural Other 
 
 
    
 
   
3.376±0.533 3.210±0.518 28 4 Ser  
0.999 1.000 
 9 4 RF , Hn , 
Esm ,  Ra 
5 F , Pc ,  BI , αn 
, P 
0 ---- 
3.246±0.735 3.158±0.614 31 7 Thr  
0.946 0.980 
 4 3 RF, , pK’ 
, H 
1 αn 0 ---- 
3,245±0,731 3.166±0.598 32 8 His  
0.943 0.982 
 1 0 --------- 1 αc 0 ---- 
3,369±0,547 3,208±0,521 35 11 Thr  
0.996 0.999 
 3 0 --------- 3 Pβ , K0 , αc 0 ---- 
3,246±0,736 3,157±0,616 56 32 Arg  
0.943 0.979 
 5 2 pHi, , p, 3 F, α, P 0 ---- 
3,229±0,749 3,160±0,607 58 34 Gly  
0.936 0.979 
 9 7 Br  , RF , 
El , Hnc , 
Ra , Hp , 
Et 
2 Ns , Pβ 0 ---- 
3,263±0,709 3,173±0,587 65 41 
Asp 
 
0.950 0.984 
 7 3 pK' , Pr  , 
p 
3 K0 , F , αc 1 Mw 
3,349±0,584 3,202±0,534 75 51 Arg  
0.986 0.996 
 5 2 pHi, , Hnc 3 K0 , α , P 0 ---- 
3,247±0,729 3,166±0,598 76 52 Ser*  
0.946 0.983 
 0 0 --------- 0 -------- 0 ---- 
3,335±0,607 3,199±0,540 87 63 
Asn 
 
0.980 0.995 
 9 4 Br , μ , 
Pr , p 
4 Ns , αn , BI , 
V0 
1 Mw 
3,318±0,635 3,191±0,555 90 66 Arg  
0.974 0.992 
 16 9 Br , RF , 
pK’ , 
pHi , EI , 
Ra , Hp , 
Ht , Et 
7 F , Mv ,  αc , 
Ns , P , BI , P 
0 ---- 
3,287±0,680 3,178±0,579 106 82 Lys  
0.960 0.987 
 4 3 Br , pHi , 
Et 
1 Ns 0 ---- 
3,368±0,550 3,207±0,524 108 84 His  
0.995 0.998 
 6 3 pHi , Hnc , 
p 
3 F , αc , P 0 ---- 
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Sites 
 
 
PAML 
ω / PP (BEB)   TreeSAAP properties 
Co
do
n 
Am
in
o 
ac
id
 
 M2a M8  
To
ta
l 
Chemical Structural Other 
3,367±0,551 3,208±0,523 117 93 Gln  
0.995 0.999 
 5 3 Br , pHi , 
Et 
2 BI , αc 0 ---- 
3,229±0,757 3,150±0,628 127 103Val  
0.936 0.976 
 1 0 --------- 1 αn 0 ---- 
             
dN/dS ratio (ω) and Bayesian analysis (BEB) posterior probabilities (PP) obtained with the NJ topology are shown for sites 
with PP>0.95 in M8 that also have a PP>0.90 in M2a. TreeSAAP analysis results present the total number of radical 
changes in amino acid properties and their assigned categories. Type I sites are shown in bold. *Site 52 had only strong 
support when using the NJ topology. 
 
To evaluate if the sites under selection were only variant in angiogenin or throughout the RNase A 
superfamily, the primate ANG sequences were compared with a pool of 168 non-angiogenin sequences 
using the ConSurf server. This software calculates evolutionary conservation scores (1 to 9), based on 
alignments and a reference structure (human ANG 3D-structure) (Figure 12).  
The sites under positive selection in the primate sequences presented low conservation scores of 1, 
except for site 52 that had a score of 3, although scores for sites 32, 34 and 52 were bellow the 
confidence cut-off for ConSurf. When analyzed in the pool of RNase sequences, sites 11, 84 and 103 
presented a high conservation score of 7; whereas sites 4, 8, 51 and 34, 93 had moderate 
conservation scores of 5 and 4 respectively. The remaining sites had lower scores. It is striking that 
eight of the fifteen sites detected under selection in the primate ANG gene are highly or moderately 
 
Figure 12 – Conservation scores for sites under positive selection 
Plot comparing the conservation scores obtained in ConSurf for the sites under positive of the fourteen primate angiogenin 
genes used in this study and a pool of 168 non-angiogenin RNase. 
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conserved in this superfamily, including three of the five type I sites. Although this may partly be a result 
of the structural and functional divergence between its members, it also indicates that these sites are 
not subject to random variation throughout the superfamily due simply to structural and functional 
permissiveness. 
4.3. Structure-function analyses. 
To envisage possible structure-function implications of positive selected sites in the ANG gene, the 
candidate sites were mapped on the ANG X-ray structure (Figure 13). Sites clustered in particular 
regions of the protein structure, a good indication of a non-random event. Four of the five positive 
selection clusters were located within known ANG functional regions: clusters 1 and 2 in the active site 
region, cluster 3 in the nuclear localization signal and cluster 4 in the ‘cell-binding’ site. Interestingly, 
positive selection appears to act in all ANG’s regions currently deemed essential for its angiogenic 
function.  
In order to obtain further insights into the structural variations introduced in these regions by the 
sites under positive selection, a structural evolutionary portrait was produced using homology modeling. 
For each of the main positive selection clusters, structural models are presented for each node and 
species individually, superimposed and zooming on type I sites showing only the relevant nodes and 
species (according to treeSAAP branch results, Annex II). These are presented in the following sections. 
Available functional information for amino acids in the previously defined clusters was compiled in Table 
6. 
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Figure 13 – Map of sites under positive selection and ANG functional regions 
The three main functional regions of ANG are represented in the centre image: (i) the ribonucleolytic active site with the 
main functional amino acid side chains depicted as ball and stick; (ii) the nuclear localization signal and (iii) the “Cell-
Binding” site. Lateral images highlight the five structural clusters of sites under positive selection. 
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Table 6 – Functional information for sites in and around positive selection clusters 
Site Functional information Selection 
Ser4 None ++ 
Arg5 Conserved site, unique to ANG (RNase counterpart is Ala4), has been implicated in the 
formation of hydrogen bonds with the P2 phosphate and appears to be the critical residue 
in this subsite [28, 32, 117]. Involved in the contacts of the complex ANG-ribonuclease 
inhibitor (RI). [118] 
 
Thr7 None + 
His8 Structural counterpart of the RNase A P2 subsite residue Lys7 lays 4.5Å apart from the P2 
phosphate group in superimposed structures, too far to interact with it. Forms H-bonds 
with Arg33 [28]. Involved in the contacts of the complex ANG-RI. [118] 
+ 
Phe9 Part of the hydrophobic nucleus. Forms π-π interactions with catalytic residue His13. 
[119] 
 
Leu10 Mutation to proline disrupts ribonucleolytic activity (disrupts interaction 9-13). [119]  
Thr11 Structural counterpart of the RNase A P2 subsite residue Arg10, but lays too far from the 
P2 phosphate group in superimposed structures to form interactions [28]. 
+ 
Gln12 Structural analogue of the RNase A P1 subsite residue Gln11 [28]. 
Mutation to proline disrupts ribonucleolytic activity (disrupts interaction 9-13). [119] 
 
His13 Member of the catalytic triad - general base catalysis. [28]  
Arg31  
Arg32 
Mutation to alanine reduces nuclear translocation efficiency 
[23].  
Involved in the contacts of the complex ANG-RI. [118] 
+ 
Arg33 Mutation to alanine disrupts nuclear translocation [23] and 
reduces ribonucleolytic activity by 7 fold [32]. 
Interacts with Phe45 and shields Met30 and Cys26 from 
solvent. [119] 
H bonds with Thr11 and Tyr14 and Ser28 [28]. 
 
Gly34  ++ 
Leu35 
Region 31-35 
constitutes a nuclear 
localization signal 
responsible for the 
nucleolar location of 
angiogenin [23] 
  
Lys40 Member of the catalytic triad - donates H bond to the pentavalent transition state. 
Conservative replacement with arginine causes a 50 fold reduction in activity [120]. 
Involved in the contacts of the complex ANG-RI. [118] 
 
Asp41 Involved in the contacts of the complex ANG-RI. [118] ++ 
Ile42 Structural counterpart of the RNase A B1 subsite residue Val43. [28]  
Asn43 Structural counterpart of the RNase A B1 subsite residue Asn44. [28]  
Arg51 Flexible residue [28]. Appears disordered in the ANG–RI complex x-ray structure [118]. + 
Ser52 Forms H-bonds with Asn61.[28] + 
Ile53 Part of the hydrophobic core, essential to the ribonucleolytic activity. [119]  
Asn61 Deamination abolishes angiogenic activity. [22] Forms H-
bonds with Ser 52 and 74. [28] 
 
Gly62   
Asn63 
The region 60-68 
constitutes a critical cell-
binding site, distinct from 
the catalytic site. [21] 
Forms H-bonds with Gly62. [28] ++ 
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Site Functional information Selection 
Pro64   
His65   
Arg66  ++ 
Glu67 Involved in the contacts of the complex ANG-RI. [118]  
Thr80 Structural counterpart of the RNase A B1 subsite residue Asp83. [28]  
Lys82 None + 
His84 The region 84-89 is involved in the contacts of the complex ANG-RI. [118] ++ 
Cys92 Forms an S-S bond with Cys39. [28]  
Gln93 Involved in the contacts of the complex ANG-RI. [118] + 
Tyr94 Forms H-bonds with Lys-40 and is part of the hydrophobic core, mutation to asparagine 
abolishes ribonucleolytic activity. [119] 
 
Val103 Part of the hydrophobic core, mutation to Asp abolishes ribonucleolytic activity. [119] + 
Sites under positive selection are indicated in the last column, (++) type I sites, (+) type II sites. 
4.3.1. The active site region 
As expected, due to functional constraints, no evidence for positive selection was detected in the 
critical amino acids of the P1, B1 or B2 catalytic subsites. Cluster-1 of sites under positive selection was 
located in the subsite P2 region, and included type I site, 4 (Ser) and three type II sites: 7 (Thr), 8 (His) 
and 11 (Thr). These sites were all located within the first α-helix (H1), neighboring several conserved 
important amino acids (Table 6).  Site 4 presented the greatest diversity of drastic changes in chemical 
and structural properties, linked to polarity, hydrophobicity, bulkiness and structural conformation 
(Table 5). A more reduced diversity was obtained for site 7 mostly reflecting chemical changes, whereas 
sites 8 and 11 had few and mostly conformational properties under positive selection.  
At the structural level, the presence of a proline in site 4 for two of the sequences analyzed, 
Colobus guereza and Macaca mulatta, was noteworthy (Figure 14D). This amino acid is known to cause 
the kinking of α-helices (reviewed in [121]) and could thereby affect the local structure of this region. 
The structural model for Macaca mulatta presented a significant backbone distortion that was not so 
pronounced in the case of Colobus guereza. However, the overall structure of this region did not appear 
to be significantly affected, given the good positional overlap between the side chains of critical amino 
acids like neighboring Arg5 and also Phe9 and His13. The role played by site 4 located at the beginning 
of the helix is perhaps allowing some distortion without significantly affecting the position of critical 
amino acids.  
Cluster-2 included four selected sites, type I sites 41 (Asp) and 84 (His), type II sites 82 (Lys) and 
93 (Gln), located close or within the anti-parallel β-sheet formed by β-strands B1, B4 and B5. Sites 41 
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and 82 lie at the C-terminal region of the active site, while sites 84 and 93 are located further up, facing 
the exterior of the protein.  
Site 41, neighbouring two important active site residues Lys40 [P1 subsite], Ile42 and Asn43 [B1 
subsite] (Table 6), presented a total of seven amino acid properties suffering drastic changes, namely 
properties pertaining polarity and size/molecular weight (Table 5). At the structural level, some 
backbone deviations were observed (Figure 15D), in particular for Pongo pygmaeus, Saguinus oedipus 
and to a lesser extent Trachypithecus francoisi, probably due to the greater flexibility allowed by the 
amino acid side chains present for these species (glycine, alanine, alanine).  However, these did not 
seem to affect surrounding active site residues. For Lys40, two main side chain conformations were 
observed, but the position of the ξ-NH2 did not appear to be significantly affected. Structure at sites 42 
and 43 also appeared to be conserved, with a good overlap for alpha-carbons and side-chains. 
 As for site 82, located close to another active site residue of the Thr80 (B1 subsite), four properties 
were detected concerning mostly the acid-base characteristics and the buriedness of the residue. The 
structure is conserved at the level of site 80, even tough the New World monkeys had an Ile in this 
position. The second site under positive selection in strand B4, site 84, presented a total of six 
properties under selection related with polarity, acid-base properties and conformational properties 
(Table 5). This chemical diversity is not paralleled at the structural level, which was mostly conserved 
for this position. 
Finally, site 93, located between conserved sites Cys92 and Tyr94 (Table 6) had a total of five 
properties detected pertaining to acid-base, size and conformation-related characteristics. The structural 
and functional importance of sites 92 and 94 for all species was clear given the conservation of the 
position of main and side chains at these positions. 
The overall results for the two clusters located in the active site region suggest that selective forces 
acted in several of the more permissive sites of subsites P2 and B1, shaping the local chemical and 
conformational environment without significantly interfering with the critical residues, which were 
probably subject to purifying selection. 
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Figure 14 – Structural evolutionary portrait of cluster 1 
(A) Tree obtained from structural reconstruction presenting the reference number for current and ancestral sequences. (B) 
Sequence alignment for current and ancestral sequences for cluster 1 sites. (C) Individual backbone traces obtained by 
homology modelling of current and ancestral sequences showing relevant amino acid side chains. (D) Superimposed 
backbone traces for all sequences (left picture) and relevant structures for the evolution of type I sites 4 (right picture) Type I 
sites are numbered in red and type II sites in pink. 
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Figure 15 – Structural evolutionary portrait of cluster 2 
(A) Tree obtained from structural reconstruction presenting the reference number for current and ancestral sequences. (B) 
Sequence alignment for current and ancestral sequences for cluster 2 sites. (C) Individual backbone traces obtained by 
homology modelling of current and ancestral sequences showing relevant amino acid side chains (D) Superimposed 
backbone traces for all sequences (centre picture) and relevant structures for the evolution of type I sites 41 and 84 (lateral 
pictures). Type I sites are numbered in red and type II sites in pink. 
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4.3.2. The nucleolar targeting sequence 
Cluster-3 of sites under positive selection is located in the NLS region with a type I site 34 (Gly) and 
a type II site 32 (Arg). Analysis of drastic changes in amino acid properties for site 32 resulted in a total 
of five properties indicative of changes in polarity and helical conformation (Table 5). Site 34 had an 
elevated number of drastic changes in properties as a result of the disparity of amino acid substitutions 
observed between specific branches (Figure 16B). The structural models shown a slight degree of 
backbone divergence in both sites 32 and 34 (Figure 16D). The same was observed for site 33, 
considered critical in human ANG import, albeit not conserved in all the species analyzed. The diversity 
of chemical and structural amino acid properties changes presented by sites 32 and 34 has a clear 
potential to influence the interactions with other proteins mediated by this region. However, further 
characterization of the pathway for nuclear import or retention and the interactions performed in the 
process would be necessary to fully assess the impact and possible causes for positive selection in this 
region. 
4.3.3. The cell binding site 
Cluster-4 of sites under positive selection partly overlaps with the cell-binding site, including two 
type I sites: 63 (Asn) and Arg66 and a type II site: Val103. Site 103 (Val) is a buried residue, but was 
also included in this cluster, since its α-carbon is within the range distance observed for sites 63 and 
66 (93-63: 10.84 Å; 93-66: 12.84 Å; 63-66: 9.98 Å). For the first of these sites, a total of nine 
properties were subjected to drastic changes: four chemical properties, four structural properties and 
one uncategorized property (Table 5). These were mostly related to polarity and volume/spatial 
occupation. Site 66 presented the highest number of properties subject to drastic changes in this 
analysis (16 out of 31 properties) - nine chemical and seven structural (Table 5). The superimposed 
structural models presented only slight backbone diverge (Figure 17D), more pronounced in the case of 
site 63, not very different from the ones observed for neighboring sites. As for the previous cluster, the 
evolutionary changes observed here for sites 63 and 66 have a potential to influence the interactions 
performed by this region. However, these need to be further characterized at the structural level. 
Site 103 is part of the hydrophobic core of the enzyme (Table 6) and only one structural property 
was detected as being under selection. The observed amino acid changes (Figure 17B) were 
replacements between branched-chain amino acids, conservative in terms of hydrophobicity. 
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Figure 16 – Structural evolutionary portrait of cluster 3 
(A) Tree obtained from structural reconstruction presenting the reference number for current and ancestral sequences. (B) 
Sequence alignment for current and ancestral sequences for cluster 3 sites. (C) Individual backbone traces obtained by 
homology modelling of current and ancestral sequences showing relevant amino acid side chains (D) Superimposed 
backbone traces for all sequences (left picture) and relevant structures for the evolution of type I site 34 (right picture). Type 
I sites are numbered in red and type II sites in pink. 
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Figure 17 – Structural evolutionary portrait of cluster 4 
(A) Tree obtained from structural reconstruction presenting the reference number for current and ancestral sequences. (B) 
Sequence alignment for current and ancestral sequences for cluster 4 sites. (C) Individual backbone traces obtained by 
homology modelling of current and ancestral sequences showing relevant amino acid side chains (D) Superimposed 
backbone traces for all sequences (left picture) and relevant structures for the evolution of type I site 63 (right picture) and 
66 (left picture). Type I sites are numbered in red and type II sites in pink. 
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4.3.4. Clusters outside know functional regions 
Cluster-5 had two type II sites, 51 (Arg) and 52 (Ser), located in helix 3 outside of the main 
functional regions. The support for site 52 as being under selection was weak, only obtained with the NJ 
topology in PAML. As for site 51 no particular functional or structural information was available, besides 
being a rather flexible residue (Table 6) that is exposed to the solvent. It has a total of five properties 
with drastic changes, mostly concerning acid-base and conformational characteristics. 
4.4. Driving forces for diversifying selection 
The evidence presented in this study for molecular adaptation selective pressures acting in all the 
essential regions for ANG-induced angiogenesis is a good indication that angiogenesis is the major 
reason for diversifying selection in this gene. However, it remains elusive whether it is the physiological 
or pathophysiological involvement of ANG that underlies molecular adaptation. Previously, Zhang et al. 
[53] compared ANG evolution to another cancer-related protein under positive selection BRCA1 [122] 
and, based on the fact that most tumours appear after reproductive age, they suggested that the 
selective pressures acting in these genes were more likely related to the physiological roles of their 
encoded proteins and not with cancer promotion. In the same report the authors hypothesized that 
diversifying selection could also be the result of an evolutionary ‘conflict of interests’ between mothers 
and foetuses, give the importance of ANG in pregnancy to embryo vascularization.  
The idea of ‘evolutionary conflict of interests’ was further developed by Crespi and Summers [123] 
in relation to cancer. These authors suggested that antagonistic coevolution was the cause for the links 
between positive selection at the molecular level and increased cancer risk. This hypothesis is 
supported by the fact that positive selection is often the result of ongoing conflicts between more or less 
dependent opposing parties: host and pathogen, sperm and eggs, mothers and foetuses, maternal and 
paternal genes (epigenetic regulation) among others. In the same sense, the genetic, developmental 
and physiological processes that participate in antagonistic coevolution, like resource acquisition and 
use, cellular replication and tissue growth are also critical for cancer predisposition. By this hypothesis, 
the strong selective pressures resulting from this antagonism would drive the changes in conflict-related 
genes and traits, and the increased cancer risk would be a pleiotropic effect of these changes.  
However, could other causes also influence selection in the ANG gene? Several lines of evidence 
support the existence of other ANG functions: (i) the expression of ANG mRNA is low in the embryo and 
only reaches a maximum level in the adult, a pattern not temporarily related to vessel development 
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[124]; (ii) ANG is a component of normal serum that is upregulated in acute phase responses, 
suggesting an involvement in host injury response [125]; (iii) human ANG antimicrobial activity was 
demonstrated in vitro [14, 15], but it is still unknown whether this is a result of the ribonucleolytic 
activity or some other effect. The possible ANG involvement in injury response and innate immunity 
constitutes another intriguing hypothesis for a positive selection driving force. The constant “arms-race” 
between host and pathogens is well known for maintaining a strong selective pressure in immunity-
related genes. A similar possibility was raised in the mouse [48], whose six paralogous ANG genes were 
shown to be under positive selection, two of which presenting an antimicrobial activity (ANG1 and 
ANG4). The role of ANG4 in gut innate immunity was characterized in vivo [14]. Further in vivo 
characterization of human/primate ANG anti-microbial effects is required in order to assess this 
hypothesis. Nonetheless, it is yet another possibility that is compatible with the hypothesis of 
evolutionary conflict and cancer involvement. 
Finally, it is also important to consider the role that interacting proteins and ligands may have in 
the evolution of ANG. We evaluated the solvent exposure of the residues detected to be under positive 
selection by analyzing the accessible surface area (ASA) using GETAREA [114] (Figure 18). This 
program estimates if a residue is exposed at the surface or buried inside the protein, based on the ratio 
 
Figure 18 – Exposure of residues to the exterior of the protein 
A plot of the ASA ratio between the side-chain and the ‘radom coil’ value of the residue. Sites with a ratio above 50% are 
considered to be exposed at the surface of the protein while sites under 20% are considered to be buried inside. The 
localization of sites is shown on a wireframe representation of ANG. 
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between side-chain ASA and the “random coil” values per residue. Eleven of the fifteen sites presented 
an ASA ratio equal or above 50% (7, 8, 32, 34, 41, 51, 63, 66, 84, and 93), three above 40% (4, 11, 
and 52) and only one bellow 20% (103). The majority of the sites is therefore exposed at the surface of 
the protein and can a priori modulate the interactions with other proteins or ligands. It is also 
noteworthy that some of the sites detected under positive selection in this study were found to be 
involved in contacts with the ribonuclease inhibitor (RI) in the crystal structure of the ANG-RI complex 
(table 5). More precise structural characterizations of the interactions performed by ANG and its 
partners are still lacking. This will be critical to assess which amino acids and regions of the protein are 
involved in them.  
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In this work I aimed at pinpointing the amino acid sites under positive selection in the primate ANG 
gene and assess the possible structural and functional implications of selection in these positions. 
Using a maximum likelihood analysis of 14 ANG sequences, representative of the three main braches of 
the simian primates, I retrieved strong evidence of positive selection in the ANG gene. Posterior 
Bayesian analysis of maximum likelihood estimates allowed the identification of fifteen sites in the 
sequence with strong probability for being under positive selection. These results were further 
complemented by an evolutionary analysis of drastic changes in amino acid in which five of the previous 
15 sites also presented with a high number of properties.  
Eight of the 15 sites under selection in the primate ANG gene were highly or moderately conserved 
in the RNase A family and their mapping in the ANG 3D-structure revealed a clustered pattern, 
suggesting that this was not a random event but instead the result of a directional force. Furthermore, 
four of the five clusters were located within the main functional regions of the protein. Two of the 
clusters were located in the active site region, one in the N-terminal side close to the entry and 
overlapping with subsite B2 and other on the C-terminal side, close to the P1 and B1 subsites. Both of 
them included sites neighboring well conserved amino acids that are critical for the catalytic activity. 
Although some of the sites presented a diverse set of chemical and structural amino acid properties, 
they did not appear to have a significant impact in the overall structure of these regions, as assess by 
comparison of 3-D structural homology models of current species and their ancestrals. Selective 
pressures at the active site appear to have modulated the chemical and structural characteristics of a 
few permissive sites without affecting the overall position of the critical residues. The other two clusters 
within functional regions are located in the NLS and CB regions, two regions potentially involved in 
mediating protein-protein interactions that are essential for the angiogenic function of ANG. A significant 
divergence in chemical and structural amino acid properties was observed at some of the sites, clearly 
having a potential to influence the interactions performed through these regions.  
More precise assessments of structural and functional implications of positive selection were 
hindered by the lack of adequate structural characterizations of the interactions performed by ANG. As 
mentioned before, the active site is blocked at the level of the B1 subsite and the putative active 
conformation with a bound substrate was never crystallized. The same holds true for the NLS and CB 
regions that, despite the models and proposed interactions, are still lacking crystallographic structures 
detailing the contacts established and the amino acids involved. 
Given that positive selection evidences were found in all ANG functional regions required for 
angiogenesis, it is tempting to indicate angiogenesis as the process under selection. The question of 
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whether it is the physiological or pathophysiological involvement of ANG that underlies molecular 
adaptation remains open. A recent hypothesis proposed antagonistic co-evolution as the link between 
increased cancer risk and positive selection, given that the genetic, developmental and physiological 
process that participate in antagonistic co-evolution, like resource acquisition and use, cellular 
replication and tissue growth, are also critical for cancer predisposition. In this sense the cancer 
involvement of ANG would be a secondary effect of positive selection for its physiologic roles. 
However, other processes may be influencing ANG’s adaptative evolution, and the possible 
involvement in innate immunity is particularly interesting since the host-pathogen ‘arms-race’ is a 
common origin for selective pressure. Also, the possibility of ANG/ligands co-evolution must be 
considered, given that most sites under selection are exposed to the surface of the protein and can 
mediate interactions. Future experimental characterizations of ANG function, physiologic mechanisms 
and interactions will allow further evaluation of these hypotheses. 
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The work presented on this thesis has allowed a further characterization of positive selection on the 
primate ANG gene, but as with all scientific work, it has raised some new questions and left others 
unanswered. The theoretical setting of the lab and the amount of sequences available from previous 
works, in addition to the human implications of this gene, dictated that the focus was on simian 
primates. The study could be expanded to more primates, including prosimians, and further analysis 
could be performed to determine if positive selection is focused on specific branches of this order. 
Moreover, the progressive availability of genomes has made available other mammalian species that 
could be retrieved either directly (if genomes are annotated) or by data mining procedures. Previous 
genomic analysis of the RNase superfamily by Cho and Zhang [48, 49] has characterized the ANG 
genes of the mouse, rat, dog, cow and opossum and some other sequences are available from other 
works. These can be used to perform a larger study on mammals, although the number of primate 
species to include should be carefully considered, in order to reduce the possible biases. 
Additionally, the functional and structural analyses presented before were only based on data 
available on the scientific literature and direct observations from 3-D homology models. A more precise 
evaluation of the structural effects of positive selection and further characterization of the positive 
selection clusters could be achieved through computational molecular dynamics (MD) simulations 
(reviewed in [126]). Two main directions could be explored using these methodologies: 
1. Despite the natural constraints of ANG active site and the lack of crystallographic structures 
involving substrates constitute limiting factors, further analysis on the effects of positive 
selection in this region is still possible. Two previous works from Madhusudhan et al. performed 
substrate docking and MD simulations with ANG [127, 128] to analyze binding, active site 
topology and explain substrate specificity. In the first study, the coordinates of 3’-CMP in 
complex with bovine RNase A were transferred to bovine ANG, by superimposing the two 
structures using the catalytic histidines and the ξ-NH2 of the catalytic lysine as anchors. The 
resulting mononucleotide-containing structure served as basis for the second study were the 
CMP group was transferred to human ANG and used as a template for building CpA and UpA 
dinucleotide ANG complexes. In all the cases, the obstruction of the B1 subsite prevailed and no 
alternative conformation for Gln117 was found to allow the opening of this site. To circumvent 
this problem, the authors chose to change the conformation of the C-terminal region in order to 
allow the docking of the first base.   
A similar strategy could be used to dock substrates to previously described models and perform 
MD simulations, with the aim of comparing any differences in binding and substrate specificity 
Chapter 6 
STRUCTURAL AND FUNCTIONAL IMPLICATIONS OF POSITIVE SELECTION ON THE PRIMATE ANGIOGENIN GENE 50 
induced by the different sites under positive selection. Homology model quality is a critical issue 
in this type of work and the option to use Swiss-Model, although suitable for the basic structural 
comparisons performed in this work, would probably not be the best. A recent benchmark 
study of six modeling softwares [129] – Modeller, SegMod/ENCAD, SWISS-MODEL, 3D-
JIGSAW, nest, and Builder – shown that although none of them outperformed all others in every 
test, three clearly displayed a better performance - Modeller, nest, and SegMod/ENCAD. One of 
the main limitations of this approach would evidently be the artificial manipulation of the C-
terminal region and the differential effects it could have on the structural backgrounds of each 
model.  
2. The fact that the sites with a high probability for being under positive selection appeared 
clustered in specific regions and the ConSurf conservation scores demonstrating that several of 
them where quite conserved on the RNase A superfamily were good indications that this is a 
non-random directed event. Nonetheless, the possibility that some of the observed divergence 
is a result of local structural permissiveness remains open, in particular for the clusters located 
in the NLS and CB regions. This issue could also be addressed in a MD simulation with an 
increasing temperature to determine the regions with a higher RMSD (a measure of the 
distance between the same atoms in different simulations) as an indication of a higher 
structural flexibility. 
These are some of the many questions that remain open in the path to understand this peculiar 
enzyme and its involvement in angiogenesis, health and disease. As Sir Winston Churchill so eloquently 
said in the past: 
 
“Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end 
of the beginning” 
Sir Winston Leonard Spencer Churchill K.G. (1874–1965) at a speech given after the British defeat of the German Afrika Korps at the Second Battle of El 
Alamein in Egypt (1942-11-10) 
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Annex A – Angiogenesis in disease 
Table 1 – Diseases characterized or caused by abnormal or excessive angiogenesis  
Organ  Diseases in mice or humans Angiogenic mechanism 
 
Cancer Activation of oncogenes; loss of tumour suppressors. 
Infectious diseases Pathogens express angiogenic genes [130], induce 
angiogenic programs [131] or transform Ecs [132]. 
Numerous organs  
Autoimmune disorders Activation of mast cells and other leukocytes. 
 
Vascular malformations Tie-2 tyrosine-kinase receptor mutations [133].  
DiGeorge syndrome Low VEGF and neuropilin-1 expression [134]. 
Osler-Weber-Rendu syndrome Mutations of endoglin or ALK-1 [135]. 
Cavernous haemangioma Loss of gap-junction proteins connexin 37 and connexin 
40 [136]. 
Blood vessels  
Atherosclerosis; transplant 
arteriopathy 
 
 
Adipose tissue  Obesity Angiogenesis induced by fatty diet; weight loss by 
angiogenesis inhibitors [137]. 
 
Skin  Psoriasis, warts, allergic 
dermatitis, scar keloids, 
pyogenic granulomas, blistering 
disease, Kaposi sarcoma in 
AIDS patients [132]. 
 
 
Persistent hyperplasic vitreous 
syndrome  
Loss of Angiopoietin-2  [138, 139] or  VEGF164 [140] 
Choroidal neovascularisation TIMP-3 (Tissue Inhibitor of Metalloproteinases 3 ) 
mutation [141]. 
Eye  
Diabetic retinopathy; 
Retinopathy of prematurity 
 
 
Primary pulmonary hypertension Germline BMPR-2 mutation [142]; somatic EC 
mutations [143-145] 
Respiratory system  
Asthma; nasal polyps  
 
Intestines  Inflammatory bowel and 
periodontal disease, ascites, 
peritoneal adhesions 
 
 
Reproductive system  Endometriosis, uterine bleeding, 
ovarian cysts, ovarian hyper 
stimulation [146] 
 
 
Bone, joints  Arthritis, synovitis, osteomyelitis, 
osteophyte formation[147]  
 
(Adapted from [148]) 
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Table 2 - Diseases characterized or caused by insufficient angiogenesis or vessel regression  
Organ  Disease in mice or humans  Angiogenic mechanism  
 
Alzheimer disease  Vasoconstriction, microvascular degeneration and  cerebral 
angiopathy due to EC toxicity by amyloid-β [149] 
Amyotrophic lateral sclerosis; 
Diabetic neuropathy  
Impaired perfusion and neuroprotection, causing motoneuron 
or axon degeneration due to insufficient VEGF production 
[150]  
Nervous system  
Stroke  Correlation of survival with angiogenesis in brain [151]; stroke 
due to arteriopathy (Notch-3 mutations [152])  
 
Atherosclerosis  Characterized by impaired collateral vessel development 
[153] 
Hypertension  Microvessel rarefaction due to impaired vasodilatation or 
angiogenesis [154] 
Diabetes  Characterized by impaired collateral growth [155] and 
angiogenesis in ischemic limbs [156], but enhanced retinal 
neovascularisation secondary to pericyte dropout  
Blood vessels  
Restenosis  Impaired re-endothelialisation after arterial injury at old age 
[157]  
 
Gastric or oral ulcerations Delayed healing due to production of angiogenesis inhibitors 
by pathogens [158].   
Gastrointestinal 
Crohn disease  Characterized by mucosal ischemia  
 
Hair loss  Retarded hair growth by angiogenesis inhibitors [159]. Skin  
Skin purpura, telangiectasia 
and venous lake formation  
Age-dependent reduction of vessel number  and maturation 
(SMC dropout) due to EC telomere shortening [160]. 
 
Pre-eclampsia  EC dysfunction resulting in organ failure, thrombosis and 
hypertension due to deprivation of VEGF by soluble Flt-1 
[161]. 
Reproductive 
system  
Menorrhagia  
(uterine bleeding)  
Fragility of SMC-poor vessels due to low Ang-1 production 
[162]. 
 
Neonatal respiratory distress  Insufficient lung maturation and surfactant  production in 
premature mice due to reduced HIF-2 and VEGF production 
[163].  
Lung  
Pulmonary fibrosis, 
emphysema  
Alveolar EC apoptosis upon VEGF inhibition [164]. 
 
Kidney  Nephropathy  Age-related vessel loss due to TSP-1 production  [165]. 
 
Bone  Osteoporosis, impaired bone 
fracture healing  
Impaired bone formation due to age dependent  decline of 
VEGF- driven angiogenesis [166]; angiogenesis inhibitors 
prevent fracture healing [167]. 
 
(Adapted from [148]) 
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Annex B – TreeSAAP Results 
Table 1 - TreeSAAP results per branch 
Amino acid 
change 
Site  Branch 
 
From To 
 Properties 
(positive selection) 
 
 Node9 → Colobus g.  Ser Pro  Hnc, Esm 
 Node7 → Macaca m.  Ser Pro  Hnc, Esm 
 Node7 → Papio h.  Ser Phe  None 
 Node1 → Node11  Ser Ile  Pc, F, P 
 Node11 → Saguinus o.  Ile Leu  None 
4 
 Node12 → Saimiri s.  Ile Ser  BI, RF, αn, Ra 
 
 
 Node1 → Node5  Thr Arg  None 
 Node1 → Node11  Thr Ile  None 7 
 Node11 → Saguinus o.  Ile Asn  RF, pK', h, αn 
 
 Node2 → Node3  Asp His  αc 
 Node1 → Node11  Asp Lys  None 8 
 Node11 → Saguinus o.  Lys Arg  None 
 
 Node8 → Miopithecus t.  Thr Ser  None 
 Node5 → Node20  Thr Ala  K0 
 Node2 → Pongo p.  Thr Ala  K0 
 Node1 → Node11  Thr Asp  Pβ 
11 
 Node11 → Saguinus o.  Asp Glu  αc 
 
 Node9 → Colobus g.  Arg Lys  αc 
32 
 Node1 → Node11  Arg Leu  pHi, p, F, αc, P 
 
 Node5 → Node6  Gly His  Ns, Pβ, Br, RF, El, Hnc, Ra, Hp, Et 
34 
 Node1 → Node11  Gly Asn  RF, Ra 
 
 Node9 → Colobus g.  Asp Ala  K0, Pr, p 
 Node2 → Pongo p.  Asp Gly  pK'  , F, Pr 
 Node1 → Node11  Asp Glu  αc  
41 
 Node11 → Saguinus o.  Glu Ala  K0, Mw, Pr 
 
 Node5 → Node20  Arg His  Hnc, αc 
 Node1 → Node11  Arg Ala  K0, pHi, P 51 
 Node11 → Saguinus o.  Ala Glu  None 
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Amino acid 
change 
Site  Branch 
 
From To 
 Properties 
(positive selection) 
 
 Node1 →  Node5  Ser His  None 
52 
 Node8 → Miopithecus t.  His Ser  None 
 
 Node7 → Macaca m.  Asn Ser  Ns, Br, μ 
 Node1 → Node11  Asn Glu  Ns 
 Node11 → Saguinus o.  Glu Val  Pr, p, αn 
63 
 Node12 → Saimiri s.  Glu Gln  BI, Mw, V0, αm 
 
 Node1 → Node5  Arg Gly  pKa, pHi, F, Mv, αc, P 
 Node10 → Trachypithecus f.  Gly Arg  Ns, Pβ, BI, Br, RF, EI, Ra, Hp, Ht, Et 66 
 Node1 → Node11  Arg Asn  pHi, αc 
 
 Node1 → Node5  Arg Gly  pHi 
 Node7 → Macaca m.  Gly Arg  Ns, Br, P 
 Node7 → Papio h.  Arg Asn  Ns, Br, P 
82 
 Node11 → Node12  Arg Gly  None 
 
 Node7 → Papio h.  Arg His  Hnc, αc 
 Node1 → Node2  Arg His  Hnc, αc 84 
 Node11 → Node12  Arg Ile  pHi, F, p, αc, P 
 
 Node5 → Node6  Arg Gln  BI, pHi, αc 
 Node7 → Papio h.  Gln Arg  None 
 Node2 → Pongo p.  Gln His  Br, Et 
 Node1 → Node11  Gln Arg  None 
93 
 Node11 → Saguinus o.  Arg Gln  BI, pHi, αc 
 
 Node2 → Node3  Ile Val  αn 
 Node11 → Saguinus o.  Ile Val  αn 103 
 Node12→ Aotus t.  Ile Leu  None 
 
 
